Chronic diarrhea medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Chronic diarrhea}} {{CMG}}; {{AE}} {{DAMI}} ==Overview== ==Medical Therapy== ==References== {{Reflist|2}} {{WH}} {{WS}}" |
|||
Line 6: | Line 6: | ||
==Medical Therapy== | ==Medical Therapy== | ||
{{familytree/start}} | |||
{{familytree | | | A01 | | | A01= Adults with chronic diarrhea (> 4 weeks)}} | |||
{{familytree | | | |!| | | | }} | |||
{{familytree | | | B01 | | | B01=<div style="float: left; text-align: left; height: 36em; width: 30em; padding:1em;"> '''Characterize the symptoms:'''<br> | |||
❑ Onset (congenital, abrupt or gradual) <br> ❑ Pattern (continuous or intermittent) <br> ❑ Duration <br> ❑ Stool characteristics (watery, bloody or fatty) <br> ❑ [[Fever]] <br> ❑ [[Abdominal pain]] <br> ❑ [[Weight loss]] <br> ❑ Fecal incontinence | |||
---- | |||
'''Obtain a detailed history:'''<br> | |||
❑ Aggravating factors ([[diet]] or [[stress]]) <br> ❑ Over-the-counter drugs or use of prescription <br> ❑ Previous evaluations (objective records, radiograms or [[biopsy]] specimens) <br> ❑ Radiation therapy or surgery <br> ❑ Factitious diarrhea (eating disorders, laxative ingestion, [[secondary gain]] or [[malingering]]) <br> ❑ Systemic disease ([[cancer]], [[diabetes]], [[HIV]], [[hyperthyroidism]]) <br> | |||
---- | |||
'''Elicit the epidemiological factors:'''<br> | |||
❑ Travel before the onset of illness <br> | |||
❑ Exposure to contaminated food or water <br> | |||
❑ Illness in other family members </div>}} | |||
{{familytree | | | |!| | | }} | |||
{{familytree | | | C01 | | | C01=<div style="float: left; text-align: left; height: 29em; width: 30em; padding:1em;"> '''Examine the patient:'''<br> | |||
'''Assess the volume status:''' <br> | |||
❑ General condition <br> | |||
❑ Thirst <br> | |||
❑ [[Pulse]] <br> | |||
❑ [[Blood pressure]] <br> | |||
❑ Eyes <br> | |||
❑ Mucosa | |||
---- | |||
'''Perform a general physical exam:'''<br> | |||
❑ Skin ([[flushing]], [[rash]]es or dermatographism) <br> ❑ Oral cavity (ulcers) <br> ❑ Cardiovascular system (murmur)<br> ❑ Respiratory system (wheezing) <br> ❑ [[Thyroid]] (mass) <br> ❑ [[Abdomen]] ([[ascites]], [[hepatomegaly]], mass or tenderness) <br> ❑ Anorectal ([[Abscess]], blood, [[fistula]] or sphincter competence) <br> ❑ Extremities ([[edema]]) </div>}} | |||
{{familytree | | | |!| | | | }} | |||
{{familytree | | | D01 | | | | D01=<div style="float: left; text-align: left; height: 12em; width: 30em; padding:1em;"> '''Order routine laboratory tests:''' | |||
❑ [[CBC|CBC and differential]] <br> ❑ [[ESR]] <br> ❑ [[Serum electrolytes]]<br> ❑ Total serum [[protein]] and [[albumin]] <br> ❑ [[Thyroid function tests]] <br> ❑ [[Urinalysis]] <br> | |||
</div>}} | |||
{{familytree | | | |!| | | | }} | |||
{{familytree | | | D10 | | | | D10= <div style="float: left; text-align: left"> '''Start altered diet:'''<br> ❑ Stop lactose products <br> ❑ Avoid alcohol and high osmolar supplements <br> ❑ Drink 8-10 large glasses of clear fluids (fruit juices, soft drinks etc) <br> ❑ Eat frequent small meals (rice, potato, banana, pastas etc) <br> | |||
---- | |||
❑ '''Start [[oral rehydration therapy]] or [[intravenous fluids]] depending on the hydration status'''</div>}} | |||
{{familytree | | | |!| | | | | }} | |||
{{familytree | | | D02 | | | | | D02 = '''Any specific obvious diagnosis through history and examination?'''}} | |||
{{familytree | |,|-|^|-|.| | }} | |||
{{familytree | D03 | | D04 | | D03= <div style="float: left; text-align: left; width: 30em; padding:1em;">Yes </div>| D04=<div style="float: left; text-align: left; width: 30em; padding:1em;">No </div>}} | |||
{{familytree | |!| | | |!| | }} | |||
{{familytree | D05 | | |!| | D05= <div style="float: left; text-align: left; height: 22em; width: 30em; padding:1em;"> '''Chronic infection (outbreaks or endemic areas)'''<br> ❑ Trial of oral [[metronidazole]] 500 mg TID for 5 days for protozoal diarrhea<br> ❑ Oral [[ciprofloxacin]] 500 mg BD X 3 days for enteric bacterial diarrhea | |||
----- | |||
'''Medication induced:''' <br> | |||
❑ Discontinuation of the drug | |||
----- | |||
'''Irritable bowel syndrome''' (chronic abdominal pain and altered bowel habits in the absence of any organic disorder)<br> | |||
❑ Trial of antispasmodic agents (oral [[dicyclomine]] 20 mg QID),OR <br> | |||
❑ [[Tricyclic antidepressant|TCA's]]([[amitriptyline]] 10-25 mg OD), OR <br> | |||
❑ [[SSRI]] ([[fluoxetine]] 20-40 mg OD), OR <br> | |||
❑ [[Rifaximin]]</div>}} | |||
{{familytree | |!| | | |!| | }} | |||
{{familytree | E01 | | |!| | E01= No resolution of the diarrhea}} | |||
{{familytree | |`|-|v|-|'| | }} | |||
{{familytree | | | F01 | | | F01=<div style="float: left; text-align: left; line-height: 150% "> '''Order stool analysis:'''<br> | |||
❑ [[Diarrhea laboratory findings#Fecal Weight|Stool weight]] <br> ❑ [[Diarrhea laboratory findings#Stool Osmotic Gap|Stool electrolytes and fecal osmotic gap]] <br> ❑ [[Diarrhea laboratory findings#Fecal pH|Stool pH]] <br> ❑ [[Diarrhea laboratory findings#Occult Blood|Fecal occult blood testing]] <br> ❑ [[Diarrhea laboratory findings#White Blood Cells|Stool WBC's]] <br> ❑ Stool fat: [[Diarrhea laboratory findings#Fecal Fat Concentration and Output|Quantitative]] / [[Diarrhea laboratory findings#Sudan Stain for Fat|Sudan stain]] <br> ❑ [[Diarrhea laboratory findings#Analysis for Laxatives|Laxative screen]] </div>}} | |||
{{familytree/end}} | |||
This management is as per the American Gastroenterological Association guidelines for the evaluation and management of chronic diarrhea.<ref name="pmid10348831">{{cite journal| author=| title=American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. | journal=Gastroenterology | year= 1999 | volume= 116 | issue= 6 | pages= 1461-3 | pmid=10348831 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10348831 }} </ref> | |||
<br> | |||
==References== | ==References== |
Revision as of 13:14, 7 June 2017
Chronic diarrhea Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
Medical Therapy
Adults with chronic diarrhea (> 4 weeks) | |||||||||||||||||
Characterize the symptoms: ❑ Onset (congenital, abrupt or gradual) Obtain a detailed history: Elicit the epidemiological factors: | |||||||||||||||||
Examine the patient: Assess the volume status: Perform a general physical exam: ❑ Oral cavity (ulcers) ❑ Cardiovascular system (murmur) ❑ Respiratory system (wheezing) ❑ Thyroid (mass) ❑ Abdomen (ascites, hepatomegaly, mass or tenderness) ❑ Anorectal (Abscess, blood, fistula or sphincter competence) ❑ Extremities (edema) | |||||||||||||||||
Order routine laboratory tests:
❑ CBC and differential | |||||||||||||||||
Start altered diet: ❑ Stop lactose products ❑ Avoid alcohol and high osmolar supplements ❑ Drink 8-10 large glasses of clear fluids (fruit juices, soft drinks etc) ❑ Eat frequent small meals (rice, potato, banana, pastas etc) ❑ Start oral rehydration therapy or intravenous fluids depending on the hydration status | |||||||||||||||||
Any specific obvious diagnosis through history and examination? | |||||||||||||||||
Yes | No | ||||||||||||||||
Chronic infection (outbreaks or endemic areas) ❑ Trial of oral metronidazole 500 mg TID for 5 days for protozoal diarrhea ❑ Oral ciprofloxacin 500 mg BD X 3 days for enteric bacterial diarrhea Medication induced: Irritable bowel syndrome (chronic abdominal pain and altered bowel habits in the absence of any organic disorder) | |||||||||||||||||
No resolution of the diarrhea | |||||||||||||||||
Order stool analysis: ❑ Stool weight ❑ Stool electrolytes and fecal osmotic gap ❑ Stool pH ❑ Fecal occult blood testing ❑ Stool WBC's ❑ Stool fat: Quantitative / Sudan stain ❑ Laxative screen | |||||||||||||||||
This management is as per the American Gastroenterological Association guidelines for the evaluation and management of chronic diarrhea.[1]
References
- ↑ "American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea". Gastroenterology. 116 (6): 1461–3. 1999. PMID 10348831.